Gabelli Funds LLC Reduces Holdings in HCA Healthcare, Inc. $HCA

Gabelli Funds LLC decreased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 46.0% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 17,350 shares of the company’s stock after selling 14,760 shares during the period. Gabelli Funds LLC’s holdings in HCA Healthcare were worth $8,100,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Capital World Investors increased its position in shares of HCA Healthcare by 3.8% in the 3rd quarter. Capital World Investors now owns 4,959,336 shares of the company’s stock worth $2,113,662,000 after purchasing an additional 179,443 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its position in shares of HCA Healthcare by 1.8% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 2,065,225 shares of the company’s stock worth $880,199,000 after purchasing an additional 36,414 shares during the last quarter. Viking Global Investors LP increased its position in shares of HCA Healthcare by 58.5% in the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after purchasing an additional 690,773 shares during the last quarter. Legal & General Group Plc increased its position in shares of HCA Healthcare by 0.8% in the 3rd quarter. Legal & General Group Plc now owns 1,124,511 shares of the company’s stock worth $479,267,000 after purchasing an additional 8,478 shares during the last quarter. Finally, Invesco Ltd. increased its position in shares of HCA Healthcare by 1.1% in the 3rd quarter. Invesco Ltd. now owns 1,100,929 shares of the company’s stock worth $469,216,000 after purchasing an additional 11,829 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on HCA shares. Truist Financial dropped their target price on shares of HCA Healthcare from $546.00 to $535.00 and set a “buy” rating for the company in a research report on Monday, April 27th. Mizuho boosted their price objective on shares of HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a research report on Wednesday, February 25th. Sanford C. Bernstein lowered their price objective on shares of HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating for the company in a research report on Tuesday, April 28th. UBS Group boosted their price objective on shares of HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a research report on Monday, February 23rd. Finally, Weiss Ratings lowered shares of HCA Healthcare from a “buy (b)” rating to a “buy (b-)” rating in a research note on Monday. Sixteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $515.77.

HCA Healthcare Trading Down 4.4%

Shares of NYSE:HCA opened at $403.98 on Wednesday. The company has a 50 day moving average of $473.90 and a 200-day moving average of $485.20. The firm has a market cap of $89.62 billion, a P/E ratio of 13.89, a P/E/G ratio of 1.34 and a beta of 1.18. HCA Healthcare, Inc. has a twelve month low of $330.00 and a twelve month high of $556.52.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The company had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The company’s revenue was up 4.3% on a year-over-year basis. During the same period in the prior year, the company posted $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities research analysts forecast that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s dividend payout ratio is currently 10.73%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.